首页> 外文期刊>The Journal of Nuclear Medicine >Usefulness of Standardized Uptake Values for Distinguishing Adrenal Glands with Pheochromocytoma from Normal Adrenal Glands by Use of 6-18F-Fluorodopamine PET
【24h】

Usefulness of Standardized Uptake Values for Distinguishing Adrenal Glands with Pheochromocytoma from Normal Adrenal Glands by Use of 6-18F-Fluorodopamine PET

机译:使用6-18F-氟罗帕明PET来区分正常肾上腺与嗜铬细胞瘤的肾上腺与标准化摄取值的实用性

获取原文
获取外文期刊封面目录资料

摘要

id="p-1">6-18F-Fluorodopamine (18F-FDA) PET is a highly sensitive tool for the localization of pheochromocytoma (PHEO). The aim of this study was to establish cutoff values for pathologic and physiologic adrenal gland tracer uptake. >Methods: 18F-FDA PET with CT coregistration was performed in 14 patients (10 men and 4 women; age [mean ?± SD], 42.9 ?± 13.3 y) with unilateral adrenal gland PHEO and in 13 control subjects (5 men and 8 women; age, 51.7 ?± 12.5 y) without PHEO. Standardized uptake values (SUVs) were compared between adrenal glands with PHEO and normal left adrenal glands in control subjects. >Results: 18F-FDA accumulation was observed in all adrenal glands with PHEO and in 6 of 13 control adrenal glands (P = 0.02). The SUV was higher in adrenal glands with PHEO (mean ?± SD, 16.1 ?± 6.1) than in 18F-FDA-positive control adrenal glands (7.7 ?± 1.4) (P = 0.005). SUV cutoffs for distinguishing between adrenal glands with PHEO and normal adrenal glands were 7.3 (100% sensitivity) and 10.1 (100% specificity). >Conclusion: The SUVs of adrenal foci on 18F-FDA PET facilitate the distinction between adrenal glands with PHEO and normal adrenal glands.
机译:id =“ p-1”> 6- 18 F-氟罗帕明( 18 F-FDA)PET是一种高度敏感的嗜铬细胞瘤(PHEO)定位工具。这项研究的目的是建立病理和生理学肾上腺示踪剂摄取的临界值。 >方法: 18 F-FDA PET结合CT成像在14例患者中进行(男10例,女4例;平均年龄[±SD],42.9±±13.3岁)有单侧肾上腺PHEO的患者和13名无PHEO的对照受试者(5名男性和8名女性;年龄51.7±12.5岁)。在对照组中比较了具有PHEO的肾上腺和正常左肾上腺的标准摄取值(SUVs)。 >结果: 18 在所有患有PHEO的肾上腺和13个对照肾上腺中有6个中观察到F-FDA积累( P = 0.02)。在具有PHEO的肾上腺中,SUV值高于 18 F-FDA阳性对照肾上腺(7.7?±1.4)( P < / em> = 0.005)。区分PHEO肾上腺和正常肾上腺的SUV截止值为7.3(敏感性为100%)和10.1(特异性为100%)。 >结论: 18 F-FDA PET上的肾上腺焦点SUV有助于区分PHEO肾上腺和正常肾上腺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号